MCMarija Cauchi

Marija Cauchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marija Cauchi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline

    by Marija Cauchi, Mark Willis, Angela Andrews, Matthijs Backx, Wallace Brownlee, Helen L Ford, Bruno Gran, Stephen Jolles, Sian Price, Waqar Rashid, et al.

    Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receiving disease-modifying therapies. This article explores the risk of infection in people with MS and provides guidance—developed by Delphi consensus by specialists involved in their management—on how to screen for, prevent and manage infection in this population.


  • Open Access

    Interpretation of vaccine associated neurological adverse events: a methodological and historical review

    by Marija Cauchi, Harriet Ball, Yoav Ben-Shlomo, Neil Robertson

    As a result of significant recent scientific investment, the range of vaccines available for COVID-19 prevention continues to expand and uptake is increasing globally. Although initial trial safety data have been generally reassuring, a number of adverse events, including vaccine induced thrombosis and thrombocytopenia (VITT), have come to light which have the potential to undermine the success of the vaccination program. However, it can be difficult to interpret available data and put these into context and to communicate this effectively. In this review, we discuss contemporary methodologies employed to investigate possible associations between vaccination and adverse neurological outcomes and why determining causality can be challenging. We demonstrate these issues by discussing relevant historical exemplars and explore the relevance for the current pandemic and vaccination program. We also discuss challenges in understanding and communicating such risks to clinicians and the general population within the context of the ‘infodemic’ facilitated by the Internet and other media.